Algeria Pharmaceuticals & Healthcare Report Q3 2012 - New Market Report Now Available
BMI View: With the push into emerging markets by pharmaceutical companies and the dangers of importing drugs into the Algerian market well documented, it makes sense that large multinational drugmakers would want to partner with local companies. High rates of foreign direct investment in the past year also indicate that the Deloitte Vision 2012 report on the viability of using Algeria as a hub for the production of biologics was a success, and its recommendations have been at least internalised...
View full press release